Document Detail


A report from the 47th Annual Meeting of the American Society of Clinical Oncology (June 3-7, 2011 - Chicago, Illinois, USA).
MedLine Citation:
PMID:  21971543     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Improving survival, as well as the quality of life and functioning of survivors, is the main objective of cancer therapy, for which a very large number of drugs are currently available or under development as therapeutic candidates. Information on many of these compounds was discussed during the 2011 American Society of Clinical Oncology (ASCO) meeting in Chicago. The number of news presentations discussed during the meeting was incredibly high, with plenary, oral abstract, poster discussion and general poster sessions filling room upon room. The following report provides a quick review of major new research into drug and support therapies for cancer as presented at the meeting.
Authors:
X Rabasseda; M Gómez-Zaera
Related Documents :
17790973 - Ancient and modern, rock and fluid meet in san francisco.
22564333 - Abstracts of the american society of hypertension, inc. twenty-seventh annual scientifi...
21562003 - Inadequate reporting of research ethics review and informed consent in cluster randomis...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drugs of today (Barcelona, Spain : 1998)     Volume:  47     ISSN:  1699-3993     ISO Abbreviation:  Drugs Today     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-10-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160518     Medline TA:  Drugs Today (Barc)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  693-737     Citation Subset:  IM    
Copyright Information:
Copyright 2011 Prous Science, S.A.U. or its licensors. All rights reserved.
Affiliation:
Thomson Reuters, Barcelona, Spain. xavier.rabasseda@thomsonreuters.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tissue transglutaminase antibodies in celiac disease: focus on the pediatric population.
Next Document:  Arsenite induces cell transformation by reactive oxygen species, AKT, ERK1/2, and p70S6K1.